AWARDDEFINITIVE CONTRACTOther than small business
Definitive contract 75A50325C00020RAFA LABORATORIES LTD
Overview
Award facts
- Net obligations
- $33.39M
- $33,392,937of $46.21M potential value
- Outlays (paid to date)
- $20.14M
- $20.14M paid of $33.39M obligated$20,142,033
- Period of performance
- Sep 30, 2025 to Sep 29, 2027
- Ends in 10 months
- Modifications
- 1
- Latest action Jul 29, 2026
- Contract type
- Definitive contract
- PIID 75A50325C00020
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
RAFA ATROPINE AUTO-INJECTORS (0.5 MG, 1 MG, AND 2 MG)
Dates and value
- Award date
- Signed on Sep 30, 2025
- Potential end of performance
- Sep 29, 2028
- Current value
- $33,392,937Base and exercised options
- Potential value (if all options are exercised)
- $46,212,577
Obligations by fiscal year of action
- FY2026: $12,446,520
- FY2025: $20,946,417
Total across 2 fiscal years: $33,392,937
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 29, 2026. View on USAspending · Recipient on SAM.gov
Recipient
LocationJERUSALEM, ISR
UEICKDNTKNDPMJ6
CAGE code0905A
Business sizeOther than small businessSize at award, per the contracting officer
Parent companyRAFA LABORATORIES LTD
Business types and certifications
Foreign-ownedFor-profit organizationManufacturer of goods
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Funded by
- Department of Health and Human Services
- Office Of Assistant Secretary For Preparedness And Response
- ASPR/ORM-SNS
- Funded from
- Administration for strategic preparedness and responseProgram activities075-1000Federal accounts (agency financial reports)
Place of performance
- Place of performance
- 97770 Israel
Classification and competition
Classification
- Product or service (PSC)
- 6505DRUGS AND BIOLOGICALS (product)
Competition
- Extent competed
- Not competedC
- Reason not competed
- Only one source-other (FAR 6.302-1 other)ONE
- Solicitation procedures
- Only one sourceSSS
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 30, 2025Base obligation at award: $20,946,417
- Latest action
- Jul 29, 2026 — Option exercisedModification P00001; obligation change +$12,446,520
- Latest substantive action
- Jul 29, 2026 — Option exercisedModification P00001; obligation change +$12,446,520
- Actions by type
- Base award1
- Option exercised1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- No
- Simplified procedures for commercial items
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- $12,446,520
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- Foreign-owned business not incorporated in the U.S.D
- Country of product or service origin
- IsraelISR
- Place of manufacture
- Mfg outside U.S. - domestic nonavailabilityJ
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7505
- Contracting office code
- 75A503
- Transactions recorded under this award key
- 2
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7505
- Funding office code
- 75A503
- Treasury accounts
- 075-X-1000-000
- Object classes
- 26.0: Supplies and materials
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression